Detalhe da pesquisa
1.
Neoadjuvant Therapy Versus Upfront Resection for Nonpancreatic Periampullary Adenocarcinoma.
Ann Surg Oncol
; 30(1): 165-174, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-35925536
2.
Defining the Values and Quality of Life of Cancer Survivors Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: An International Survey Study.
Ann Surg Oncol
; 30(12): 7825-7832, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37535272
3.
Impact of Recombinant Granulocyte Colony-Stimulating Factor During Neoadjuvant Therapy on Outcomes of Resected Pancreatic Cancer.
J Natl Compr Canc Netw
; 22(1D): e237070, 2023 12 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38150819
4.
The use of angiotensin system inhibitors correlates with longer survival in resected pancreatic adenocarcinoma patients.
HPB (Oxford)
; 25(3): 320-329, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36610939
5.
No survival benefit with suboptimal CA19-9 response: defining effective neoadjuvant chemotherapy in resectable or borderline resectable pancreatic cancer.
HPB (Oxford)
; 25(5): 521-532, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36804826
6.
Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size.
Gut
; 71(5): 961-973, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33849943
7.
Tumor Size Differences Between Preoperative Endoscopic Ultrasound and Postoperative Pathology for Neoadjuvant-Treated Pancreatic Ductal Adenocarcinoma Predict Patient Outcome.
Clin Gastroenterol Hepatol
; 20(4): 886-897, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33278573
8.
Intratumoral budding and automated CD8-positive T-cell density in pretreatment biopsies can predict response to neoadjuvant therapy in rectal adenocarcinoma.
Mod Pathol
; 34(1): 171-183, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32661298
9.
Impact of Neoadjuvant Therapy on Survival Following Margin-Positive Resection for Pancreatic Cancer.
Ann Surg Oncol
; 28(12): 7759-7769, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34027585
10.
Optimal Management of Resectable Pancreatic Head Cancer in the Elderly Patient: Does Neoadjuvant Therapy Offer a Survival Benefit?
Ann Surg Oncol
; 28(11): 6264-6272, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33748894
11.
Neoadjuvant Chemotherapy for Pancreatic Adenocarcinoma Lessens the Deleterious Effect of Omission of Adjuvant Chemotherapy.
Ann Surg Oncol
; 28(7): 3800-3807, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33386547
12.
Outcomes of Neoadjuvant Chemotherapy Versus Chemoradiation in Localized Pancreatic Cancer: A Case-Control Matched Analysis.
Ann Surg Oncol
; 28(7): 3779-3788, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33231769
13.
A Pancreatic Cancer Multidisciplinary Clinic Eliminates Socioeconomic Disparities in Treatment and Improves Survival.
Ann Surg Oncol
; 28(5): 2438-2446, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33523364
14.
Optimal management of patients with operable pancreatic head cancer: A Markov decision analysis.
J Surg Oncol
; 124(5): 801-809, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34231222
15.
Neoadjuvant therapy versus upfront surgery for early-stage left-sided pancreatic adenocarcinoma: A propensity-matched analysis from a national cohort of distal pancreatectomies.
J Surg Oncol
; 123(1): 245-251, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33103242
16.
Predictors of early recurrence following neoadjuvant chemotherapy and surgical resection for localized pancreatic adenocarcinoma.
J Surg Oncol
; 124(3): 308-316, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33893740
17.
Integrating next-generation sequencing to endoscopic retrograde cholangiopancreatography (ERCP)-obtained biliary specimens improves the detection and management of patients with malignant bile duct strictures.
Gut
; 69(1): 52-61, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30971436
18.
Real-Time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations That Might Be Targeted With Existing Drugs or Used as Biomarkers.
Gastroenterology
; 156(8): 2242-2253.e4, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30836094
19.
KRAS amplification in metastatic colon cancer is associated with a history of inflammatory bowel disease and may confer resistance to anti-EGFR therapy.
Mod Pathol
; 33(9): 1832-1843, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32376853
20.
CA19-9 Change During Neoadjuvant Therapy May Guide the Need for Additional Adjuvant Therapy Following Resected Pancreatic Cancer.
Ann Surg Oncol
; 27(10): 3950-3960, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32318949